New program tackles smoking in HIV by easing anxiety and depression

NCT ID NCT03904186

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 9-session program that uses cognitive-behavioral techniques to help people living with HIV quit smoking by reducing anxiety and depression. 131 daily smokers who were motivated to quit took part. The goal was to see if the program led to more people staying smoke-free at 1 month and 6 months after quitting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Anhedonia anxiety anxiety disorder Cigarette Smoking Depression depressive disorder HIV infectious disease nicotine dependence Smoking Smoking Cessation substance-related disorder Tobacco Use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fenway Community Health

    Boston, Massachusetts, 02215, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Thomas Street Health Center

    Houston, Texas, 77009, United States